Neuroectodermal neoplasm
Also known as: Neuroectodermal Tumor / Neuroectodermal Tumors / Peripheral neuroectodermal tumor (morphologic abnormality) / Peripheral neuroectodermal tumor (disorder) / Neuroectodermal Tumors, Primitive, Peripheral / Ewing sarcoma / peripheral neuroectodermal tumor (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00773 | Etoposide | 1 | Completed | 1 |
DB05827 | G207 | 1 | Active Not Recruiting | 1 |
DB00313 | Valproic acid | 1 | Completed | 1 |
DB08916 | Afatinib | 1 / 2 | Completed | 1 |
DB15822 | Pralsetinib | 1 / 2 | Active Not Recruiting | 1 |
DB00853 | Temozolomide | 1 / 2 | Recruiting | 1 |
DB05759 | Cixutumumab | 2 | Completed | 1 |
DB12250 | Cixutumumab | 2 | Completed | 1 |
DB00530 | Erlotinib | 2 | Withdrawn | 1 |
DB06704 | Iobenguane | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Completed | 1 |
DB17178 | Tasadenoturev | 2 | Completed | 1 |
DB00853 | Temozolomide | 2 | Withdrawn | 1 |
DB02546 | Vorinostat | 2 | Recruiting | 1 |
DB00855 | Aminolevulinic acid | Not Available | Not Yet Recruiting | 1 |
DB14554 | Dotatate | Not Available | Recruiting | 1 |
DB13985 | Lutetium Lu 177 dotatate | Not Available | Recruiting | 1 |
DB17097 | Vorasidenib | Not Available | Available | 1 |